$24.02
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. The company has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.
Country

US

CEO

Mr. James Mackin

IPO date

1993

Employees

1,800

ISIN

US2289031005

Key stats

Open

$24.11

Volume

393.52K

Market cap

$1.17B

Prev. close

$24.11

Impl / hst vl

-

Open interest

$0.00

$22.79

Day’s Range

$24.50

$19.16

52W Range

$46.84

Valuation

50
Valuation score
Fairly Valued
P/E
97.13
P/S
2.48
P/B
2.52
Current ratio
3.86
Debt / Equity
0.36
ROE
2.66%
Gross margin
64.85%
Income growth
-41.58%
FCF growth
-13.82

Analysts estimates

Consensus rating
Buy

The average rating from top 8 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$42.84
The top 10 analysts forecasts that 12-month price may increase by 78.35%, with a low of $36.36 and a high of $50.40
$36.36
Low
$42.84
Avg
$50.40
High
Current price

Earnings

Q1 ‘26 revenue
$116.34M
Q1 ‘26 net income
$1.42M
Revenue
Net income
Previous EPS
$0.03
Estimate EPS
$0.01
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply